Prognosis and treatment for aplastic anemia require tailoring based on which mutations patients have among a handful of leukemia-related genes, according to a new study from researchers including NHLBI's Dr. Neal S. Young.
NHLBI In The News
Filter News Mentions
NHLBI's Dr. Toren Finkel joined a live radio panel discussion on the Diane Rehm Show to discuss his anti-aging research involving work on mice. Other panel members included National Institute on Aging's Dr. Mark Mattson and Massachusetts Institute of Technology's Leonard Guarente.
Dr. Gary H. Gibbons, director of the NHLBI, and Dr. George Mensah, director of NHLBI’s Center for Translational Research and Implementation Science, co-authoed a study published in the Journal of the American Heart Association. The study examined the factors existing at the state level that may influence cardiovascular health outcomes.
NHLBI Director Dr. Gary H. Gibbons recently spoke to medical reporters about the future of individualized medicine and highlighted the role the National Institutes of Health is poised to play in moving this field forward.
The National Academy of Sciences announced today the election of 84 new members and 21 foreign associates from 15 countries in recognition of their distinguished and continuing achievements in original research, including NHLBI's Warren J. Leonard, M.D., chief of the Laboratory of Molecular Immunology and director of the Immunology Center.
NHLBI-supported researchers from the University of Pittsburgh School of Medicine have identified a group of genes that appear to play a key role in the development of congenital heart disease, the most common type of birth defect. The study, conducted in mice, appears in the journal Nature
NHLBI-supported scientists at the Gladstone Institutes have discovered why some heart tissue turns into bone, and they may have learned how to stop it.
NHLBI-supported researchers at Johns Hopkins have successfully corrected the genetic error that causes sickle cell disease in blood cells grown in the lab, suggesting that such cells could one day be used to treat patients.
NHLBI-funded researchers at Brigham and Women's Hospital found that a genetic risk score identified individuals at increased risk for cardiovascular death or a heart attack, both in individuals with and without known coronary disease, with individuals in the highest genetic risk score group having more than a 70 percent increase in the risk of cardiovascular death or a heart attack compared to the lowest risk group
NHLBI-funded researchers from The University of Texas Health Science Center and other locations found evidence to support the use of a battlefield blood transfusion protocol for severely injured trauma patients. The study detailing these findings appears in the Journal of the American Medical Association.